Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty

• Status: Completed
• Trial end date: 2013-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Can risedronate given once weekly for 6 months prevent periprosthetic bone loss after uncemented total hip arthroplasty?

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Danderyd Hospital
• Collaborator: Sanofi
• Treatments: Etidronic Acid; Risedronate Sodium; Risedronic Acid

Criteria

Inclusion Criteria:

• Patients on the waiting list for a total hip arthroplasty

• Primary osteoarthritis

• Osteoarthritis secondary to congenital dislocation of the hip

Exclusion Criteria:

• Rheumatoid arthritis

• Bisphosphonate treatment

• Osteomalacia

• Hypocalcemia

• Previous surgery of the affected hip